Sign in

AVD on NYSE

AMERICAN VANGUARD CORP

AMERICAN VANGUARD CORP is an American agricultural chemicals company, incorporated in Delaware.1 It is headquartered in Newport Beach, California.1 Its shares trade on NYSE under the symbol AVD.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with CVR PARTNERS, LP, Bioceres Crop Solutions Corp. or The Scotts Miracle-Gro Company, or pick any stock.

  • TickerAVD on NYSE1
  • IndustryAgricultural Chemicals1
  • HeadquartersNewport Beach, California1
  • Incorporated inDE2
  • Business address4695 Macarthur Court, Newport Beach, Ca 926602
  • Filer categoryAccelerated filer2

See how the biggest companies compare on our leaderboards

American Vanguard Corporation (“AVD”) was incorporated under the laws of the State of Delaware in January 1969 and operates as a holding company. The Company conducts its business through its principal operating subsidiaries, including AMVAC Chemical Corporation (“AMVAC”) for its domestic business and AMVAC Netherlands BV (“AMVAC BV”) for its international business.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

28.6%Gross margin4
-5.5%Operating margin4
-9.7%Net margin4
-5.9%Revenue growth, 20254
-25.9%Return on equity4
0.90×Debt to equity4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

US Crop brought in 71% of the revenue AMERICAN VANGUARD CORP broke down this way in fiscal 2025.

  1. US Crop$221.4M471%down 3% from 2024
  2. US Non-Crop$90.3M429%up 10% from 2024
Products and services by year
Products and services202320242025
US Crop$269.2M$228.3M$221.4M
US Non-Crop$75.3M$82.4M$90.3M

Regions

United States brought in 62% of the revenue AMERICAN VANGUARD CORP broke down this way in fiscal 2025.

  1. United States$311.7M462%up 0% from 2024
  2. South and Central America$119.0M424%up 1% from 2024
  3. Mexico$43.2M49%down 11% from 2024
  4. Australia$15.7M43%down 28% from 2024
  5. Canada$8.8M42%up 3% from 2024
  6. Europe$1.8M40%down 4% from 2024
  7. Africa$1.4M40%down 76% from 2024
  8. Middle East$732.0K40%down 1% from 2024
Regions by year
Regions202320242025
United States$344.5M$310.7M$311.7M
South and Central America$117.7M$118.2M$119.0M
Mexico$49.8M$48.5M$43.2M
Australia$19.7M$21.7M$15.7M
Canada$12.3M$8.5M$8.8M
Europe$2.2M$1.9M$1.8M
Africa$3.7M$5.6M$1.4M
Middle East$1.4M$739.0K$732.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue70¢$367.6M
  • Research and development4¢$23.2M
  • Selling, general and admin21¢$110.6M
  • Interest4¢$18.5M
  • Income tax1¢$2.7M

Out of $515.1M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$515.1M in 2025+10% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $468.2M$468.2M20192020: $458.7M$458.7M2020−2%2021: $557.7M$557.7M2021+22%2022: $609.6M$609.6M2022+9%2023: $579.4M$579.4M2023−5%2024: $547.3M$547.3M2024−6%2025: $515.1M$515.1M2025−6%
Gross profit56784$147.6M in 2025−17% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $177.4M$177.4M20192020: $172.6M$172.6M2020−3%2021: $170.7M$170.7M2021−1%2022: $192.4M$192.4M2022+13%2023: $179.2M$179.2M2023−7%2024: $120.3M$120.3M2024−33%2025: $147.6M$147.6M2025+23%
Operating income56784-$28.3M in 2025
-$150.0M-$100.0M-$50.0M0$50.0M2019: $26.2M$26.2M20192020: $22.9M$22.9M2020−13%2021: $30.9M$30.9M2021+35%2022: $40.7M$40.7M2022+31%2023: $23.3M$23.3M2023−43%2024: -$101.6M-$101.6M20242025: -$28.3M-$28.3M2025−72%
Net income56784-$49.9M in 2025
-$150.0M-$100.0M-$50.0M0$50.0M2019: $13.6M$13.6M20192020: $15.2M$15.2M2020+12%2021: $18.6M$18.6M2021+22%2022: $27.4M$27.4M2022+47%2023: $7.5M$7.5M2023−73%2024: -$126.3M-$126.3M20242025: -$49.9M-$49.9M2025−61%

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
Net sales$515.1M$547.3M$579.4M
Cost of sales-$367.6M-$427.0M-$400.2M
Gross profit$147.6M$120.3M$179.2M
Selling, general and administrative-$110.6M-$119.6M-$116.9M
Research, product development and regulatory-$23.2M-$32.7M-$38.0M
Product liability claims-$9.7M$0$0
Transformation-$7.2M-$20.2M-$957.0K
Asset impairment-$25.4M-$50.4M$0
Gain from sale of assets$249.0K$1.0M$0
Operating (loss) income-$28.3M-$101.6M$23.3M
Change in fair value of equity investments, net-$437.0K-$2.4M-$359.0K
Interest and other interest expenses, net-$18.5M-$16.5M-$12.6M
(Loss) income before provision for income taxes-$47.2M-$120.5M$10.3M
Provision for income taxes-$2.7M-$5.9M-$2.8M
Net (loss) income-$49.9M-$126.3M$7.5M
(Losses) earnings per common sharebasic-$1.75-$4.50$0.27
(Losses) earnings per common shareassuming dilution-$1.75-$4.50$0.26
Weighted average shares outstandingbasic28.4M shares28.1M shares28.1M shares
Weighted average shares outstandingassuming dilution28.4M shares28.1M shares28.5M shares

Compare AMERICAN VANGUARD CORP with another company

Corporate structure

AMERICAN VANGUARD CORP sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of AMERICAN VANGUARD CORP

  • AMERICAN VANGUARD CORP Newport Beach, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What AMERICAN VANGUARD CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$181.8M4 Dec 31, 2025$179.1M4 Dec 31, 2024+1.5%
Accumulated depreciation$128.7M4 Dec 31, 2025$120.9M4 Dec 31, 2024+6.5%
Property and equipment, net$53.0M4 Dec 31, 2025$58.2M4 Dec 31, 2024−8.8%
Operating-lease assets (leased space)$16.8M4 Dec 31, 2025$19.7M4 Dec 31, 2024−14.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$04 Dec 31, 2025$19.7M4 Dec 31, 2024−100.0%
Intangible assets, net (excluding goodwill)$138.7M4 Dec 31, 2025$150.5M4 Dec 31, 2024−7.8%
Indefinite-lived intangibles (excluding goodwill)$313.8M4 Dec 31, 2025$311.3M4 Dec 31, 2024+0.8%
Accumulated amortization$175.0M4 Dec 31, 2025$160.8M4 Dec 31, 2024+8.9%
Finite-lived intangibles, net$138.7M4 Dec 31, 2025$150.5M4 Dec 31, 2024−7.8%

Inventory

ItemLatestA year beforeChange
Inventory, total$176.0M4 Dec 31, 2025$179.3M4 Dec 31, 2024−1.8%
Raw materials$27.1M4 Dec 31, 2025$24.7M4 Dec 31, 2024+9.8%
Finished goods$149.0M4 Dec 31, 2025$154.6M4 Dec 31, 2024−3.7%

Properties, in its own words

AMVAC owns in fee simple the Facility constituting approximately 152,000 square feet of improved land in Commerce, California (“Commerce”) on which its West Coast manufacturing, some of its warehouse facilities and some of its manufacturing administrative offices are located.

AMVAC owns in fee simple approximately 72,000 square feet of warehouse, office and laboratory space on approximately 118,000 square feet of land in Commerce, California, which is leased to AMVAC. In 2013, the Company made a significant investment in the Glenn A. Wintemute Research Center, which houses the Company’s primary research laboratory supporting synthesis, formulation and other new product endeavors.

The rest of Item 2

In 2001, AMVAC completed the acquisition of a manufacturing facility (the “Axis Facility”) from E.I. DuPont de Nemours and Company (“DuPont”). The Axis Facility was one of three such units located on DuPont’s 510-acre complex in Axis, Alabama. The acquisition consisted of a long-term ground lease of 25 acres and the purchase of all improvements thereon. The facility is a multi-purpose plant designed for synthesis of active ingredients and formulation and packaging of finished products. In 2018, FMC Corporation acquired from DuPont a business unit, which held, among other things, the Axis Facility. Prior to expiration of the lease, AMVAC and FMC negotiated the terms of a new lease, which has a term of 15 years and the option to renew for two, 5-year periods.

On December 28, 2007, AMVAC purchased certain manufacturing assets relating to the production of Thimet and Counter and located at BASF’s multi-plant facility situated in Hannibal, Missouri (the “Hannibal Site”). Subject to the terms and conditions of the Agreement, AMVAC purchased certain buildings, manufacturing equipment, office equipment, fixtures, supplies, records, raw materials, intermediates and packaging constituting the “T/C Unit” of the Hannibal Site. The parties entered into a ground lease and a manufacturing and shared services agreement, under which BASF continues to supply various shared services to AMVAC for the Hannibal Site.

On March 7, 2008, AMVAC acquired from Bayer CropScience Limited Partnership, (“BCS LP”), a U.S. business of Bayer CropScience GmbH, a facility (the “Marsing Facility”) located in Marsing, Idaho, which consists of approximately 17 acres of improved real property. The Marsing Facility is engaged in the blending of liquid and powder raw materials and the packaging of some of the Company’s finished goods inventory in liquid, powder and pelletized formulations which are sold both in the U.S. and internationally. In addition, during 2019, the Company purchased approximately three acres of unimproved real estate immediately adjacent to the Marsing Facility for potential storage and operational use in the future.

On October 2, 2020, AMVAC completed the purchase of all outstanding shares of Agrinos which is a fully integrated biological input supplier with proprietary technology, internal manufacturing, and global distribution capabilities. Its High Yield Technology® product platform works in conjunction with other nutritional crop inputs to increase crop yield, improve soil health and reduce the environmental footprint of traditional agricultural practices. Agrinos has two primary state of the art biological production facilities, one located in Clackamas, Oregon, and a second facility in Sonora, Mexico. The Clackamas and Sonora facilities are used as both manufacturing sites and operational centers for global supply chain and logistics.

AVD regularly adds chemical processing equipment to enhance or expand its production capabilities. The Company believes its facilities are in good operating condition, are suitable and adequate for current needs and have flexibility to change products. Facilities and equipment are insured against losses from fire as well as other usual business risks. The Company knows of no material defects in title to, or encumbrances on, any of its properties except that substantially all of the Company’s assets are pledged as collateral under the Company’s credit facility agreements with its lender group. For further information, refer to Note 3 of the Notes to the Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K.

AVD sold its approximately 42 acres of unimproved land in Texas in 2025.

AVD leases approximately 19,953 square feet of office space located at 4695 MacArthur Court in Newport Beach, California. In 2020, the lease was amended and was extended to June 30, 2026. The premises have served as the Company’s corporate headquarters since 1995. AVD decided to move its headquarters to Irvine, California, in 2026.

The facilities occupied by GemChem, OHP, Envance and TyraTech (Envance and TyraTech are co-located), AMVAC BV, AMVAC M, AMVAC CR Srl, AgNova, Agrinos, AMVAC 3p and AgriCenter, consist of administration, development centers (in the case of Envance and TyraTech) and/or sales offices which are leased. In addition, AMVAC 3P leases warehouse space in Jaboticabal, Brazil.

Item 2 of the 10-K filed Mar 16, 2026.3

Leadership

Who has led AMERICAN VANGUARD CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Shayne M. Wetherall2021–2024
  2. Douglas Kaye2025–now

President

  1. Robert F. Gilbane2006–2009

Chief operating officer

  1. Trevor Thorley2009–2010
  2. Ulrich Trogele2015–2020
2010201520202025
Board members and other officers (48)

Timeline

  1. Oct 1, 20268-K Executive or director change; Regulation FD disclosure65
  2. Aug 11, 20268-K Results of operations; Regulation FD disclosure66
  3. Jun 8, 20268-K Executive or director change; Shareholder vote; Other events67
  4. Apr 15, 20268-K Executive or director change68
  5. Mar 19, 20268-K Entered a material agreement; Ended a material agreement; New debt or obligation69
  6. Mar 18, 20268-K Results of operations70
  7. Nov 12, 20258-K Results of operations; Regulation FD disclosure71
  8. Aug 19, 20258-K Entered a material agreement; New debt or obligation; Regulation FD disclosure72
  9. Aug 1, 20258-K Results of operations; Regulation FD disclosure73
  10. Jul 7, 20258-K Shareholder vote; Other events74
  11. Jun 9, 20258-K Listing notice or transfer; Regulation FD disclosure75
  12. Jun 6, 20258-K Results of operations76
  13. Jan 21, 2025New chief executive Douglas Kaye becomes CEO12
  14. Apr 23, 2021New chief executive Shayne M. Wetherall becomes CEO13

Calendar

Coming up

  1. Nov 9, 2026Reports results for the quarter ending Sep/202677

When it reported results

  1. Aug 11, 2026Reported quarterly or annual results66
  2. Mar 18, 2026Reported quarterly or annual results70
  3. Nov 12, 2025Reported quarterly or annual results71
  4. Aug 1, 2025Reported quarterly or annual results73
  5. Jun 6, 2025Reported quarterly or annual results76
  6. Mar 14, 2025Reported quarterly or annual results78
  7. Nov 12, 2024Reported quarterly or annual results79
  8. Aug 9, 2024Reported quarterly or annual results80

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

332 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 59 major events, 174 insider forms, 29 large holders, 48 other. The latest 20:

  1. Oct 1, 20268-K EDGAR
  2. Sep 30, 202610-K/A EDGAR
  3. Aug 20, 20264 EDGAR
  4. Aug 18, 20264 EDGAR
  5. Aug 11, 20268-K EDGAR
  6. Aug 10, 202610-Q EDGAR
  7. Jul 27, 2026SCHEDULE 13G/A EDGAR
  8. Jul 14, 20264 EDGAR
  9. Jun 9, 20264 EDGAR
  10. Jun 8, 20264 EDGAR
  11. Jun 8, 20264 EDGAR
  12. Jun 8, 20268-K EDGAR
  13. Jun 8, 20264 EDGAR
  14. Jun 8, 20264 EDGAR
  15. Jun 5, 20263 EDGAR
  16. Jun 5, 20264 EDGAR
  17. Jun 5, 20264 EDGAR
  18. Jun 5, 20264 EDGAR
  19. Jun 5, 20264 EDGAR
  20. Jun 5, 20264 EDGAR

The 332 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

40 open-market trades by officers, directors and large owners since October 2021: 30 buys and 10 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 18, 2026Cruiser Capital Advisors, LLCSale556,580$2.20$1.2MForm 4
Aug 17, 2026Macicek Steven DDirectorBuy19,000$2.09$39.7KForm 4
Jun 3, 2026Kaye DouglasCHIEF EXECUTIVE OFFICERBuy5,000$2.50$12.5KForm 4
May 19, 2026Gottschalk Patrick EDirectorBuy25,000$2.70$67.5KForm 4
May 13, 2026Gottschalk Patrick EDirectorBuy20,000$2.95$59.0KForm 4
May 12, 2026Gottschalk Patrick EDirectorBuy20,000$2.92$58.4KForm 4
Sep 4, 2025Eilers PeterSee RemarksSale6,000$5.35$32.1KForm 4
Jun 11, 2025Kaye DouglasCHIEF EXECUTIVE OFFICERBuy2,000$4.67$9.3KForm 4
Dec 13, 2024Eilers PeterSee RemarksSale3,000$5.35$16.1KForm 4
Nov 15, 2024Macicek Steven DDirectorBuy12,000$5.97$71.6KForm 4
Sep 4, 2024Cruiser Capital Advisors, LLCBuy7,000$6.08$42.6KForm 4
Sep 3, 2024Cruiser Capital Advisors, LLCBuy25,000$5.94$148.5KForm 4
Aug 30, 2024Cruiser Capital Advisors, LLCBuy104,492$5.74$599.8KForm 4
Aug 30, 2024WINTEMUTE ERIC GChairmanSale60,620$5.70$345.5KForm 4
Aug 29, 2024ROSENBLOOM KEITH MDirectorBuy16,480$5.74$94.6KForm 4
Aug 29, 2024WINTEMUTE ERIC GChairmanSale39,380$5.75$226.4KForm 4
Aug 29, 2024Eilers PeterSee RemarksSale5,000$5.80$29.0KForm 4
Aug 28, 2024ROSENBLOOM KEITH MDirectorBuy33,555$5.66$189.9KForm 4
May 16, 2024Trogele UlrichSee RemarksBuy18,200$8.75$159.3KForm 4
May 15, 2024ROSENBLOOM KEITH MDirectorBuy40,000$8.88$355.2KForm 4

All 40 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Douglas A. Kaye IIIChief Executive Officer57$650.0K$1.1M88
2025David T. JohnsonChief Financial Officer69$445.9K$712.2K88
2025Timothy J. DonnellyChief Legal Officer, General Counsel & Secretary66$400.0K$632.2K88
2025Shirin KhosraviChief Human Resources Officer57$300.0K$501.2K88
2025Shayne WetherallChief Executive Officer of Specialty Business60$332.8K$495.4K88
2024Douglas A. Kaye IIIChief Executive Officer57$39.6K$1.7M88
2024David T. JohnsonChief Financial Officer69$429.0K$963.3K88
2024Timothy J. DonnellyChief Legal Officer, General Counsel & Secretary66$362.9K$858.9K88
2024Shirin KhosraviChief Human Resources Officer57$276.3K$569.8K88
2023David T. JohnsonChief Financial Officer69$428.3K$688.8K88
2023Timothy J. DonnellyChief Legal Officer, General Counsel & Secretary66$362.2K$551.1K88

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Wellington Management Group Llp1,723,002$4.8M0.0%+68,107
Vanguard Capital Management LLC1,148,010$3.2M0.0%+7,266
BlackRock, Inc.933,473$2.6M0.0%−1,145,430
EVR Research LP775,000$2.2M1.1%+55,000
Dimensional Fund Advisors LP774,597$2.2M0.0%−270,213
Two Sigma Investments, LP732,819$2.1M0.0%−13,370
Cruiser Capital Advisors, LLC571,781$1.6M1.0%No change
D. E. Shaw & Co., Inc.530,006$1.5M0.0%+26
CastleKnight Management LP504,333$1.4M0.1%No change
RBF Capital, LLC418,583$1.2M0.0%New
Pullen Investment Management, LLC379,017$1.1M0.5%+4,985
Aqr Capital Management LLC372,763$1.0M0.0%+205,264
Potomac Capital Management, Inc.358,780$1.0M0.7%−263,270
Renaissance Technologies LLC355,277$994.8K0.0%+136,977
American Century Companies Inc353,869$990.8K0.0%−91,919
Geode Capital Management, LLC303,807$851.2K0.0%−359,333
Fmr LLC294,900$825.7K0.0%+24,342
Jane Street Group, LLC292,467$818.9K0.0%New
Tudor Investment Corp Et Al279,443$782.4K0.0%+78,084
Morgan Stanley209,959$587.9K0.0%−336,310
Millennium Management LLC202,524$567.1K0.0%New
Vanguard Fiduciary Trust Co178,326$499.3K0.0%+8,327
Jpmorgan Chase & Co183,467$497.2K0.0%−345,723
Russell Investments Group, Ltd.153,971$431.1K0.0%−15,300
Goldman Sachs Group Inc148,261$415.1K0.0%−25,350

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How AMERICAN VANGUARD CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAMERICAN VANGUARD CORP1
  • CIK0000005981
  • Employer ID (EIN)95-25880803
  • Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company3
  • Incorporated inDelaware3
  • Fiscal year endsDecember 311
  • Industry code (SIC)2870 Agricultural Chemicals1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address4695 Macarthur Court, Newport Beach, CA 926601
  • Phone949-260-12001
  • Shares outstanding29,500,632 as of Aug 4, 202610
  • Public float$111.1M as of Jun 30, 20253
  • AuditorDeloitte & Touche LLP, Costa Mesa, California PCAOB ID 34; it also attests to the company’s internal control over financial reporting3
  • On EDGAR sinceMay 15, 19951
  • Filings1,502 in all: 4 (766), 8-K (294), SC 13G/A (97), 10-Q (95), 3 (43), DEF 14A (29), 10-K (27), SC 13G (21)1
    All 39 form types

    DEFA14A (14), DFAN14A (14), UPLOAD (13), 4/A (12), CORRESP (7), SCHEDULE 13G/A (7), ARS (6), 10-K/A (5), 144 (5), SC 13D/A (5), 10-K405 (4), 10-Q/A (4), S-8 (4), NT 10-K (3), S-3 (3), 8-A12B (2), 8-K/A (2), CT ORDER (2), DEFC14A (2), NT 10-Q (2), PREC14A (2), S-3/A (2), SCHEDULE 13G (2), 3/A (1), 424B3 (1), 424B5 (1), 5 (1), CERTNYS (1), PRE 14A (1), PRER14A (1), PRRN14A (1)

  • Latest filingsAnnual report (10-K) Mar 16, 2026
    Quarterly report (10-Q) Aug 10, 2026
    Proxy statement (DEF 14A) Apr 23, 2026
    Latest 8-K (8-K) Oct 1, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.10 par valueAVDNew York Stock Exchange

From the cover page of the 10-K filed Mar 16, 2026 (Section 12(b) of the Exchange Act).3

Risk factors and legal proceedings

The risks AMERICAN VANGUARD CORP names in Item 1A of its 10-K filed Mar 16, 2026: 25 risks under these headings, as written.3

  • Regulatory/ Supply Chain/Other Risks
  • Compliance with environmental and other regulations or changes in such regulations or regulatory enforcement priorities could increase our cost of doing business or limit our ability to market all our products.
  • Public statements made by USEPA regarding their preliminary findings in connection with the registration review of DCPA could expose the Company to future claims for personal injury which, in turn, could adversely affect the Company’s financial performance.
  • Several of the Company’s organophosphates are subject to a petition to revoke tolerances under the FFDCA which, if granted, could result in the limitation and/or cancellation of one or more registrations for such products.
  • Product liability judgments on glyphosate and cases involving other pesticides by domestic courts present a litigation risk to companies in this industry.
  • The trend of passing pesticide “ban-bills” in various states could put one or more of the Company’s products at risk.
  • PFAS lawsuits and legislation continue to spread among many states.
  • Use of the Company’s products is subject to continuing challenges from activist groups.
  • The Company is dependent upon sole source or a limited number of suppliers for certain of its raw materials and active ingredients.
  • Our business, financial condition and results of operations could be materially affected by disruptions in the global supply chain, including risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars.
  • The manufacturing of the Company’s products is subject to governmental regulations.
  • Tariffs continue to cause disruption within the Company’s markets.
The other 14 risks
  • A change in tax laws, treaties or regulations, or their interpretation or application, could have a negative impact on our business and results of operations.
  • Use of Artificial Intelligence could lead to the disclosure of sensitive information.
  • The Company’s business may be adversely affected by weather effects and commodity prices.
  • The Company may be subject to environmental liabilities.
  • Credit and Other Risks
  • The Company’s new debt structure limits its liquidity, requires defined, minimum levels of financial performance and includes significant interest expense, and the Company may not be able to refinance on terms favorable to the Company or execute on business opportunities that may otherwise be advantageous to the Company.
  • The Company depends in part upon customer prepayments to meet its working capital needs.
  • The carrying value of certain assets on the Company’s consolidated balance sheets may be subject to impairment depending upon market trends and other factors.
  • The Company’s computing systems are subject to cyber security risks.
  • To the extent that capacity utilization is not fully realized at its manufacturing facilities, the Company may experience lower profitability.
  • Domestic and regional inflation trends, increased interest rates and other factors could lead to the erosion of economies and adversely impact the Company.
  • Acquisition/Investment Risks
  • The Company’s investment in foreign businesses may pose additional risks.
  • The Company’s growth has been fueled in part by acquisitions.
  • The Company faces competition from generic competitors that source products from countries having lower cost structures.
  • The Company’s customer base is relatively concentrated, with a small number of customers accounting for a significant portion of our sales.

Legal proceedings

Please refer to Note 5 – Litigation and Environmental of the Notes to the Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K.

The opening of Item 3, Legal Proceedings.3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88